Debut Plus

₹28,055

▲ +183.95 +0.66%

18 Jul 2026

NSE Listed

Abbott India Limited (ABBOTINDIA)

Volume: 8,282Avg Vol 1W: 12,784.8Avg Vol 1M: 15,268.6552W Range:₹25,150₹35,310
NSE BSE www.abbott.co.in
Key Ratios
Checked 18h ago
Market Cap₹59,222 Cr
Current Price₹28,055
Previous Close₹27,871.05
High / Low (52w)₹35,310 / ₹25,150
Volume8,282
Avg Vol (1W)12,784.8
Avg Vol (1M)15,268.65
Stock P/E149.96
Book Value₹2,246.68
Dividend Yield170%
ROE32.51%
ROA23.87%
Revenue (TTM)₹6,685 Cr
Revenue Growth—
Profit Margin22.4%
Total Debt—
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹730.36
P/B12.41
Debt / Equity0.02
50 DMA₹26,550.5
200 DMA₹27,437.5
Day change+0.66%
Price Chart
₹28,055▼ 17.88% · 1Y
₹35195₹2518055K
2025-07-17
2026-07-16

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 32.5%.
  • Pays a dividend yield of 170.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 150.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,558 Cr₹1,633 Cr₹1,614 Cr₹1,605 Cr₹1,738 Cr₹1,757 Cr₹1,724 Cr₹1,710 Cr
EBITDA₹440 Cr₹482 Cr₹490 Cr₹487 Cr₹499 Cr₹553 Cr₹514 Cr₹537 Cr
Net Profit₹328 Cr₹359 Cr₹361 Cr₹367 Cr₹366 Cr₹415 Cr₹376 Cr₹395 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹3,415 Cr₹3,792 Cr₹4,208 Cr₹4,391 Cr₹4,996 Cr₹5,503 Cr₹6,097 Cr₹6,685 Cr
EBITDA₹625 Cr₹701 Cr₹811 Cr₹944 Cr₹1,099 Cr₹1,290 Cr₹1,630 Cr₹1,898 Cr
Net Profit₹401 Cr₹450 Cr₹593 Cr₹691 Cr₹799 Cr₹949 Cr₹1,201 Cr₹1,414 Cr
EPS188.81211.93279.04325.04375.87446.8565.28665.62
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2,416 Cr₹2,941 Cr₹3,547 Cr₹3,840 Cr₹4,224 Cr₹4,556 Cr₹5,193 Cr₹5,917 Cr
Total Liabilities₹723 Cr₹932 Cr₹1,115 Cr₹1,238 Cr₹1,404 Cr₹1,367 Cr₹1,495 Cr₹1,684 Cr
Equity₹1,693 Cr₹2,009 Cr₹2,432 Cr₹2,602 Cr₹2,820 Cr₹3,189 Cr₹3,699 Cr₹4,233 Cr
Total Debt————————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹855 Cr₹962 Cr₹1,237 Cr₹1,234 Cr₹1,617 Cr₹1,459 Cr
Investing₹-401 Cr₹-72 Cr₹-396 Cr₹-148 Cr₹-416 Cr₹182 Cr
Financing₹-217 Cr₹-582 Cr₹-637 Cr₹-639 Cr₹-745 Cr₹-925 Cr
Free Cash Flow₹855 Cr₹962 Cr₹1,237 Cr₹1,234 Cr₹1,617 Cr₹1,459 Cr
Shareholding
Promoter 74.99% Institutions 9.2% Public 15.81%
Efficiency & Working Capital
ROCE42.5%
Interest Coverage655
Dividend Payout—
Debtor Days22 d
Inventory Days50 d
Payable Days60 d
Cash Conversion Cycle12 d
Working Capital Days72 d
Shareholding Details

As of 2026-03-31

Promoter75%
FII0.3%
DII8.9%
Institutions9.2%
Public15.8%
Promoter Pledge0%
No. of Shareholders75,866
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters75%75%75%75%75%75%75%75%75%75%75%75%
FIIs0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.3%
DIIs8.7%8.7%8.7%8.9%8.8%9%9%8.9%9.2%9.1%9%8.9%
Public16.2%16.1%16.1%15.9%16%15.9%15.8%15.9%15.7%15.7%15.8%15.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders69,58268,88572,25269,38271,58869,44967,89269,93467,58471,19975,80175,866
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Abbott Capital India LimitedShareholding of Promoter and Promoter Group50.4%1.07 Cr
Abbott Healthcare Products LimitedShareholding of Promoter and Promoter Group17.6%37,44,951
British Colloids LimitedShareholding of Promoter and Promoter Group6.9%14,70,000
Sbi Nifty Midcap 150 Momentum 50 EtfPublic Shareholding2.2%4,58,186
Canara Robeco Mutual FundPublic Shareholding1.1%2,28,178
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Abbott Capital India Limited00%2026-03-31
Abbott Healthcare Products Limited00%2026-03-31
British Colloids Limited00%2026-03-31
Canara Robeco Mutual Fund00%2026-03-31
Sbi Nifty Midcap 150 Momentum 50 Etf00%2026-03-31
Abbott Capital India Limited00%2025-12-31
Abbott Healthcare Products Limited00%2025-12-31
British Colloids Limited00%2025-12-31
Canara Robeco Mutual Fund00%2025-12-31
Sbi Large & Midcap Fund00%2025-12-31
Abbott Capital India Limited00%2025-09-30
Abbott Healthcare Products Limited00%2025-09-30
Board of Directors
NameDesignationYear
Munir ShaikhChairman (Non-Executive)2025
Kaiyomarz MarfatiaNon Executive Director2025
Anisha MotwaniIndependent Director2025
Sudarshan JainIndependent Director2025
Shalini KamathIndependent Director2025
Alison DaviesNon Executive Director2025
Sangeeta ShettyCompany Sec. & Compli. Officer2025
Kartik RajendranManaging Director2025
Vivek MohanAdditional Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹6,270 Cr98.8%
Outside India₹76 Cr1.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10282121
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-24Dividend (131/- per share)Special
forthcoming2026-07-24Dividend (525/- per share)Final
dividend2025-07-25₹475 (4750%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20251,098001101,568
2025000004
20252140000653
Company Information
Incorporated1944
ChairmanMunir Shaikh
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]; webmaster@abbo
🌐 www.abbott.co.in ↗

📍 Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aastha Spintex LimitedAatmaj Healthcare LimitedAavas Financiers LimitedAban Offshore Ltd.Abans Enterprises Ltd.ABB India LimitedAditya Birla Capital Ltd.ABCL SR IIABCL SR IVA B Cotspin India LimitedABCL FBIL LINK2027 SR K3ABCL FBIL 2028 SR F3All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search